These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 13573770)

  • 1. [The sensitivity of 189 strains of Myocobacterium tuberculosis to viomycin].
    VIALLIER J; CAYRE RM
    C R Seances Soc Biol Fil; 1957; 151(11):1925-6. PubMed ID: 13573770
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mycobacterium tuberculosis sensitivity to viomycin and in vitro titration method].
    COLETSOS P; ORIOT E; DE REGEL N
    Ann Inst Pasteur (Paris); 1957 Aug; 93(2):210-7. PubMed ID: 13470436
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.
    Maus CE; Plikaytis BB; Shinnick TM
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3192-7. PubMed ID: 16048924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental studies in vitro with viomycin panthothenate].
    COLOMBI GC; BASILICO F; TROTTA E
    G Ital Della Tuberc; 1958; 12(4):197-201. PubMed ID: 13574580
    [No Abstract]   [Full Text] [Related]  

  • 5. Bacteriological and pharmacological studies with viomycin.
    HEIN H
    Arzneimittelforschung; 1952 Nov; 2(11):521-3. PubMed ID: 13031947
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bacteriologic research on the effect of viomycin on Mycobacterium tuberculosis].
    BARTMANN K; BLISSE A; ZANDER I
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1956; 115(3):211-22. PubMed ID: 13328762
    [No Abstract]   [Full Text] [Related]  

  • 7. Some contributions to the chemotherapy of tuberculosis with viomycin from bacteriological aspect.
    TSUKAMURA M; YAMAMOTO M
    J Antibiot (Tokyo); 1959 Mar; 12(2):65-72. PubMed ID: 13654147
    [No Abstract]   [Full Text] [Related]  

  • 8. [Susceptibility test to rifampin by using quantitative analysis of Mycobacterium tuberculosis mRNA].
    Lu Y; Zhu LZ; Chu NH; Duan LS; Liang GF
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):549-52. PubMed ID: 15388006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience in sensitivity determination of Mycobacterium tuberculosis strains to cyanoacetic acid hydrazide].
    MAREK A
    Wien Med Wochenschr; 1956 Sep; 106(36):754-7. PubMed ID: 13392936
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the kanamycin-resistance of Mycobacterium tuberculosis. II. Kanamycin-sensitivity of various drug-resistant strains.
    TORII F; YAMAMOTO M; HAYASHI M; NODA Y; TSUKAMURA M
    J Antibiot (Tokyo); 1959 May; 12(3):103-4. PubMed ID: 13672895
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro activity of linezolid against Mycobacterium tuberculosis strains isoalted from Western Turkey.
    Ermertcan S; Hosgor-Limoncu M; Erac B; Tasli H; Cavusoglu C; Bozkurt H
    Jpn J Infect Dis; 2009 Sep; 62(5):384-5. PubMed ID: 19762990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resistance of Mycobacterium tuberculosis strains to antimycobacterial preparations].
    Iavors'ka HV; Puhachevs'ka LP
    Mikrobiol Z; 2006; 68(5):44-51. PubMed ID: 17388119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isolation of non-pathogenic Mycobacteria by sputum culture in pulmonary tuberculosis; source of errors in determination of antibiotic sensitivity of Mycobacterium tuberculosis].
    VIALLIER J
    Ann Biol Clin (Paris); 1954; 12(10-12):526-8. PubMed ID: 14350301
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro susceptibility testing of Mycobacterium tuberculosis complex strains isolated from seals to antituberculosis drugs.
    Bernardelli A; Morcillo N; Loureiro J; Quse V; Davenport S
    Biomedica; 2004 Jun; 24 Supp 1():85-91. PubMed ID: 15495576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
    Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G
    Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimycobacterial activity of econazole against multidrug-resistant strains of Mycobacterium tuberculosis.
    Ahmad Z; Sharma S; Khuller GK; Singh P; Faujdar J; Katoch VM
    Int J Antimicrob Agents; 2006 Dec; 28(6):543-4. PubMed ID: 17101262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New rifabutin analogs: synthesis and biological activity against Mycobacterium tuberculosis.
    Barluenga J; Aznar F; García AB; Cabal MP; Palacios JJ; Menéndez MA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5717-22. PubMed ID: 16987658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro study on cross resistance of rifampin and rifapentine for Mycobacterium tuberculosis].
    Duanmu HJ; Liu YH; Jiang GL; Wang SM; Fu YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Mar; 28(3):192-4. PubMed ID: 15854417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates.
    Erturan Z; Uzun M
    Int J Antimicrob Agents; 2005 Jul; 26(1):78-80. PubMed ID: 15950439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Initial sensitivity to streptomycin & isoniazid of Mycobacterium tuberculosis isolated from patients with primary pulmonary tuberculosis not yet treated].
    SPINA G; MESCOLINI G; ZUBIANI M
    Ann Ist Carlo Forlanini; 1958; 18(1):47-61. PubMed ID: 13595413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.